Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pelvic exenteration and its modifications

M A Rodriguwz-Bigas1, N J Petrelli

  • 1Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York USA.

American Journal of Surgery
|February 1, 1996
PubMed
Summary

Pelvic exenteration surgery for advanced pelvic cancers is complex, with significant risks and variable survival rates. Experienced surgeons at specialized centers should perform these procedures to maximize curability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of p27(Kip1) and bcl-2, cigarette smoking, and colorectal cancer risk.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2013
Same author

The effect of keratinocyte growth factor-2 on esophagogastric anastomotic wound healing in rats.

International journal of surgical investigation·2003
Same author

Early postoperative oral feeding after colectomy: an analysis of factors that may predict failure.

Annals of surgical oncology·2002
Same author

Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR.

Cancer research·2001
Same author

Local excision of rectal carcinoma.

The American surgeon·2001
Same author

Rectal cancer in hereditary nonpolyposis colorectal cancer.

American journal of surgery·2001

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastrointestinal Surgery

Background:

  • Pelvic exenteration, first reported in 1948, is a treatment for advanced pelvic cancers.
  • Modifications aim to preserve urinary or fecal continence.
  • This procedure involves radical removal of pelvic organs.

Purpose of the Study:

  • To review and discuss types, indications, contraindications, morbidity, mortality, and outcomes of pelvic exenteration.
  • To assess the effectiveness of modified procedures.
  • To provide insights for surgical decision-making in advanced pelvic cancers.

Main Methods:

  • Literature review of selected series of total and modified pelvic exenterations.
  • Analysis of reported data on morbidity, mortality, and survival rates.
  • Comparative assessment of different surgical approaches.

Main Results:

  • Morbidity rates range from 32% to 84%.
  • Postoperative mortality rates vary from 0% to 14%.
  • Five-year survival rates range from 23% to 68%.

Conclusions:

  • Pelvic exenteration is a complex procedure with substantial risks.
  • Procedures should be performed by experienced surgeons in specialized centers.
  • En bloc resection is crucial for patient curability, even with adjacent organ involvement.

Related Experiment Videos